Argon Medical Devices, a portfolio company of RoundTable Healthcare Partners, has acquired the Interventional Products business of Angiotech Pharmaceuticals for $362.5 million. The acquired business manufactures and markets disposable and reusable biopsy products for cancer diagnosis, as well as drainage catheter products and vascular interventional products. The transaction bolsters Argon's existing portfolio of interventional vascular products, adds additional biopsy product lines and further leverages its sales force within core call points. The Interventional Products business was created by RoundTable in 2003 as part of its American Medical Instruments investment; Angiotech acquired it from RoundTable in 2006 as part of its purchase of AMIH.
